The request for new information is part of the US anti-trust body’s review process, which is usually done to check if a deal has any anti-competitive consequences.
Both parties plan to promptly respond to the request, One Medical said.
Analysts have said Amazon’s limited healthcare presence should minimise antitrust issues, but there were still risks, given the company faces scrutiny over its dominant tech position in the market.
After the deal was announced, US Senator Amy Klobuchar, who is also the chairwoman of a subcommittee overseeing antitrust issues, urged the FTC to investigate the proposed deal due to Amazon’s “history of engaging in business practices that raise serious anticompetitive concerns”.
Amazon in July had agreed to buy One Medical as it sought to expand its virtual healthcare offering and add brick-and-mortar doctors’ offices.
Discover the stories of your interest
The company last month said it planned to shut down its virtual healthcare service by the end of this year, as a deal to buy One Medical awaited regulatory approval.
